Peiguo Wang

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 449 citations

Medicine, Oncology, Pharmacology +12

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen et al. · Cancer Communications · 2021 · 401 citations · Full text

Medicine, Oncology, Surgery +13

MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A

Xiao Yue, Peiguo Wang, Jun Xu et al. · Oncology Reports · 2011 · 94 citations · Full text

Medicine, Cancer Biology, Oncology +16

Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis

Ping Wang, Peiguo Wang, Becky Liu et al. · Oncotarget · 2015 · 85 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis

Zhenzhen Yin, Youyou Wang, Yue-mei Wu et al. · Cancer Management and Research · 2018 · 61 citations · Full text

Medicine, Geriatric Medicine, Oncology +14